Introduced

Passed Senate

Passed House

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · January 27, 2026

To Committee On Committees (S)

Introduced January 27, 2026

Senate

Adjourned Sine Die

2026 Regular Session

SB128

AN ACT relating to prescription drugs.

Amend KRS 304.17A-164 to define and redefine terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225,…

Drugs and Medicines Education, Higher Effective Dates, Delayed Insurance, Health Pharmacists State Agencies State Employees Actuarial Analysis Health Benefit Plan Mandate Local Mandate State Employee Health Plan Mandate

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill sets rules for how prescription drug costs are shared between health plans and patients, and requires that rebates drug manufacturers pay to insurers or middlemen be passed along rather than kept. It would apply to most types of health coverage in Kentucky, including plans for state employees and employees of public colleges and universities. The changes would take effect for health plans issued or renewed on or after January 1, 2027. Who it may affect: Kentuckians with health insurance, state employees, employees of public colleges and universities, and health insurers and pharmacy benefit managers operating in Kentucky.

Open official bill text (PDF)·Report a problem with the summary